BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36330355)

  • 21. Long-Term Outcomes of Anatomic Versus Nonanatomic Resection in Hepatocellular Carcinoma Patients with Bile Duct Tumor Thrombus: A Propensity Score Matching Analysis.
    Wu JY; Sun JX; Bai YN; Huang XX; Wu JY; Wei YG; Zhang ZB; Zhou JY; Wang YD; Cheng SQ; Yan ML
    Ann Surg Oncol; 2021 Nov; 28(12):7686-7695. PubMed ID: 33929619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China.
    Chen Y; Liu H; Zhang J; Wu Y; Zhou W; Cheng Z; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zeng Y; Liu J
    BMC Cancer; 2021 Dec; 21(1):1299. PubMed ID: 34863147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
    Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
    Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
    BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of portal hypertension on short- and long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis.
    Fu J; Chen Q; Yu Y; You W; Ding Z; Gao Y; Li H; Zeng Y
    Cancer Med; 2021 Oct; 10(20):6985-6997. PubMed ID: 34405567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propensity score analysis demonstrated the prognostic advantage of anatomical liver resection in hepatocellular carcinoma.
    Ishii M; Mizuguchi T; Kawamoto M; Meguro M; Ota S; Nishidate T; Okita K; Kimura Y; Hui TT; Hirata K
    World J Gastroenterol; 2014 Mar; 20(12):3335-42. PubMed ID: 24696614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
    Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
    Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anatomical versus non-anatomical liver resection for hepatocellular carcinoma exceeding Milan criteria.
    Li SQ; Huang T; Shen SL; Hua YP; Hu WJ; Kuang M; Peng BG; Liang LJ
    Br J Surg; 2017 Jan; 104(1):118-127. PubMed ID: 27696379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anatomic Resection for Hepatocellular Carcinoma: Prognostic Impact Assessed from Recurrence Treatment.
    Minagawa M; Mise Y; Omichi K; Ichida H; Mizuno T; Yoshioka R; Imamura H; Yanagisawa N; Inoue Y; Takahashi Y; Saiura A
    Ann Surg Oncol; 2022 Feb; 29(2):913-921. PubMed ID: 34549363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis.
    Wang Q; Li J; Lei Z; Wu D; Si A; Wang K; Wang Y; Wan X; Lau WY; Shen F
    Ann Surg Oncol; 2017 Jun; 24(6):1579-1587. PubMed ID: 28058554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching.
    Kang SH; Choi Y; Lee W; Ahn S; Cho JY; Yoon YS; Han HS
    Surg Oncol; 2020 Jun; 33():63-69. PubMed ID: 32561101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of anatomical resection and non-anatomical resection in patients with hepatocellular carcinoma: propensity score matching method.
    Molina-Romero FX; Palma-Zamora E; Morales-Soriano R; Rodríguez-Pino JC; González-Argente FX; Morón-Canis JM
    Cir Cir; 2019; 87(3):328-336. PubMed ID: 31135787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma.
    Tang Z; Liu WR; Zhou PY; Ding ZB; Jiang XF; Wang H; Tian MX; Tao CY; Fang Y; Qu WF; Dai Z; Qiu SJ; Zhou J; Fan J; Shi YH
    J Cancer; 2019; 10(22):5575-5584. PubMed ID: 31632502
    [No Abstract]   [Full Text] [Related]  

  • 34. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 35. Anatomical
    Liu H; Hu FJ; Li H; Lan T; Wu H
    World J Gastrointest Oncol; 2021 Nov; 13(11):1833-1846. PubMed ID: 34853654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 37. Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study.
    Wang L; Deng M; Ke Q; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Zeng Y
    Cancer Med; 2020 Apr; 9(8):2674-2685. PubMed ID: 32072774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma.
    Kaibori M; Kon M; Kitawaki T; Kawaura T; Hasegawa K; Kokudo N; Ariizumi S; Beppu T; Ishizu H; Kubo S; Kamiyama T; Takamura H; Kobayashi T; Kim DS; Wang HJ; Kim JM; Han DH; Park SJ; Kang KJ; Hwang S; Roh Y; You YK; Joh JW; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Nov; 24(11):616-626. PubMed ID: 28887834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma.
    Jing CY; Fu YP; Huang JL; Zhang MX; Yi Y; Gan W; Xu X; Shen HJ; Lin JJ; Zheng SS; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Oncologist; 2018 Dec; 23(12):1482-1493. PubMed ID: 30257891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study.
    Zhou YW; Li QF; Chen YY; Wang K; Pu D; Chen XR; Li CH; Jiang L; Wang Y; Li Q; Yang Y; Gou HF; Bi F; Liu JY; Chen Y; Qiu M
    Eur J Surg Oncol; 2022 Jul; 48(7):1559-1566. PubMed ID: 35115213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.